Eric Jenkins

Jenkins at the [[2018 USA Outdoor Track and Field Championships]] Eric Jenkins (born November 24, 1991) is a retired long-distance runner. In college, he ran for Northeastern University, before transferring to the University of Oregon after his junior year. At the University of Oregon, Jenkins was a two-time NCAA Champion, with victories in the 3000 metres and 5000 metres at the 2015 NCAA Division I Indoor Track and Field Championships. He began competing professionally for Nike in 2015 as part of the Nike Oregon Project. Jenkins retired from competition in 2023. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Eric Jenkins', query time: 0.03s Refine Results
  1. 1
    Old Is New, New Is Old: Hamilton in the Age of Trump

    Old Is New, New Is Old: Hamilton in the Age of Trump by Jeffrey Eric Jenkins

    Published 2016-12-01
    Get full text
    Article
  2. 2
    A systematic review of the 60 year literature: Effects of outreach programs in supporting historically marginalized and first-generation, low-income students in healthcare education

    A systematic review of the 60 year literature: Effects of outreach programs in supporting historically marginalized and first-generation, low-income students in healthcare educatio... by Eric Jenkins, Jocelyn Elizabeth Nardo, Shima Salehi

    Published 2022-01-01
    Get full text
    Article
  3. 3
    A systematic review of the 60 year literature: Effects of outreach programs in supporting historically marginalized and first-generation, low-income students in healthcare education.

    A systematic review of the 60 year literature: Effects of outreach programs in supporting historically marginalized and first-generation, low-income students in healthcare educatio... by Eric Jenkins, Jocelyn Elizabeth Nardo, Shima Salehi

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)

    Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, sta... by Kazuya Ichikado, Toru Kotani, Yasuhiro Kondoh, Hideaki Imanaka, Takeshi Johkoh, Kiminori Fujimoto, Shin Nunomiya, Tomotaka Kawayama, Masanori Sawada, Eric Jenkins, Sadatomo Tasaka, Satoru Hashimoto

    Published 2023-08-01
    Get full text
    Article

Search Tools: